Alleviation of fibrosis and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via SIRT3 activation by colchicine

Heart failure (HF) is the end stage of many cardiovascular diseases, which is often associated with myocardial hypertrophy and cardiac remodeling. Among them, pressure overload-induced myocardial injury is one of the most common causes of heart failure. Colchicine, a drug widely used in the treatmen...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Biochemical and biophysical research communications Ročník 770; s. 151957
Hlavní autoři:	Wu, Mengze, Chen, Guodong, Peng, Yuce, Luo, Suxin
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Inc 12.07.2025
Témata:	agonists Animals atrial fibrillation Colchicine Colchicine - pharmacology Colchicine - therapeutic use coronary artery disease drugs fibroblasts Fibroblasts - drug effects Fibroblasts - metabolism Fibroblasts - pathology Fibrosis Heart failure Heart Failure - drug therapy Heart Failure - metabolism Heart Failure - pathology hypertrophy Male Mice Mice, Inbred C57BL Myocardium - metabolism Myocardium - pathology Oxidative stress Oxidative Stress - drug effects risk reduction simulation models SIRT3 Sirtuin 3 - metabolism therapeutics Ventricular Remodeling - drug effects Heart failure Oxidative stress Colchicine Fibrosis SIRT3
ISSN:	0006-291X, 1090-2104, 1090-2104
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!